DBF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.242800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.795400E-01
Normal-vs-Stage2
6.448400E-01
Normal-vs-Stage3
2.838400E-01
Normal-vs-Stage4
7.327800E-01
Stage1-vs-Stage2
3.284000E-01
Stage1-vs-Stage3
4.166000E-01
Stage1-vs-Stage4
3.958000E-01
Stage2-vs-Stage3
1.492840E-01
Stage2-vs-Stage4
9.377800E-01
Stage3-vs-Stage4
1.300010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.465600E-01
Normal-vs-AfricanAmerican
6.897200E-01
Normal-vs-Asian
4.555800E-01
Caucasian-vs-AfricanAmerican
9.155400E-01
Caucasian-vs-Asian
6.071600E-01
AfricanAmerican-vs-Asian
6.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.773000E-01
Normal-vs-Female
6.205400E-01
Male-vs-Female
3.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.807800E-01
Normal-vs-Age(41-60Yrs)
8.453600E-01
Normal-vs-Age(61-80Yrs)
4.377400E-01
Normal-vs-Age(81-100Yrs)
6.915800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.411840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.991600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.489200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.466000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.662000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.317400E-01
Normal-vs-Daily Drinker
3.570400E-01
Normal-vs-Weekly Drinker
7.156400E-01
Normal-vs-Occasional Drinker
4.916800E-01
Normal-vs-Social Drinker
9.781200E-01
Non Drinker-vs-Daily Drinker
7.837600E-01
Non Drinker-vs-Weekly Drinker
7.431600E-01
Non Drinker-vs-Occasional Drinker
9.063800E-01
Non Drinker-vs-Social Drinker
2.710600E-01
Daily Drinker-vs-Weekly Drinker
6.039600E-01
Daily Drinker-vs-Occasional Drinker
6.610400E-01
Daily Drinker-vs-Social Drinker
2.027600E-01
Weekly Drinker-vs-Occasional Drinker
8.111400E-01
Weekly Drinker-vs-Social Drinker
5.493400E-01
Occasional Drinker-vs-Social Drinker
3.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.214400E-01
Normal-vs-Grade 2
8.048200E-01
Normal-vs-Grade 3
8.031400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.242100E-02
Grade 1-vs-Grade 3
1.114390E-01
Grade 1-vs-Grade 4
7.214400E-01
Grade 2-vs-Grade 3
9.601000E-01
Grade 2-vs-Grade 4
8.048200E-01
Grade 3-vs-Grade 4
8.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.372000E-01
Normal-vs-NonDiabetic
5.455400E-01
Diabetic-vs-NonDiabetic
3.047800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.259000E-01
Normal-vs-NoPancreatitis
5.078600E-01
Pancreatitis-vs-NoPancreatitis
9.554200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.919200E-01
Normal-vs-N1
6.233600E-01
N0-vs-N1
2.664400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.698400E-01
Normal-vs-TP53-NonMutant
7.569800E-01
TP53-Mutant-vs-TP53-NonMutant
2.074000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
